TTA-A2
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-111828-1 mg |
| CAS # | 953778-63-7 |
| Pricing | 1 mg, USD $250.0 |
| Biological Activity | TTA-A2 is a potent, selective and orally active t-type voltage gated calcium channel antagonist with reduced pregnane X receptor (PXR) activation. TTA-A2 is equally potent against the Cav3.1 (a1G) and Cav3.2 (a1H) channels with IC50 values of 89 nM and 92 nM, respectively, at -80 and -100 mV holding potentials. TTA-A2 can be used for the research of a variety of human neurological diseases, including sleep disorders and epilepsy[1][2]. |
| Purity | ≥99.0% |
| MWt | 378.39 |
| Formula | C₂₀H₂₁F₃N₂O₂ |